Effect of the anabolic protein hormone prolactin on human erythropoiesis.
D000328:Adult; D001772:Blood Cell Count; D001855:Bone Marrow Diseases / Q000188:drug therapy / Q000503:physiopathology; D003634:DDT / Q000506:poisoning; D048909:Diabetes Complications; D004912:Erythrocytes / Q000378:metabolism; D004920:Erythropoiesis / Q000187:drug effects*; D004921:Erythropoietin / Q000032:analysis; D005260:Female; D006470:Hemorrhage / Q000628:therapy; D006801:Humans; D007501:Iron / Q000097:blood; D007700:Kinetics; D007958:Leukocyte Count; D008875:Middle Aged; D011388:Prolactin / Q000494:pharmacology* / Q000627:therapeutic use; D013997:Time Factors
D004921:Erythropoietin; D011388:Prolactin; D003634:DDT; D007501:Iron